Allurion Technologies (ALURD) Short term Debt (2022 - 2024)

Allurion Technologies' (ALURD) quarterly Short term Debt came in at $39.0 million in Q1 2024, up 0.81% on a QoQ basis from $38.6 million in Q4 2023.

Allurion Technologies (ALURD) Short term Debt (2022 - 2024) Analysis & Trends

Allurion Technologies (ALURD) has 3 years of Short term Debt data on file, last reported at $39.0 million in Q1 2024.

Quarterly Short term Debt changed N/A year-over-year to $39.0 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $39.0 million (changed N/A YoY) and the FY2023 annual result came in at $38.6 million, down 27.58% from the prior year.
Short term Debt rose to $39.0 million in Q1 2024, from $38.6 million in the prior quarter.
In the past five years, Short term Debt ranged from a high of $57.7 million in Q3 2023 to a low of $38.6 million in Q4 2023.
A 3-year average of $48.5 million and a median of $53.4 million in 2022 frame the typical range for Short term Debt.
The widest YoY moves for Short term Debt: up 27.58% in 2023, down 27.58% in 2023.
Tracing ALURD's Short term Debt over 3 years: stood at $53.4 million in 2022, then retreated by 27.58% to $38.6 million in 2023, then climbed by 0.81% to $39.0 million in 2024.
The last three Short term Debt figures came in at $39.0 million (Q1 2024), $38.6 million (Q4 2023), and $57.7 million (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Allurion Technologies	49.18 Mn	44.13 Mn	1.23 Mn

Download Data